This inventor holds 4 USPTO granted patents and 2 EPO patents. Top assignee: Adam Mickiewicz University. Active years: 2016-2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016-2017
Title: The Innovative Contributions of Piotr Ruszkowski
Introduction
Piotr Ruszkowski, based in Suchy Las, Poland, is a prominent inventor known for his significant contributions to the field of pharmaceuticals. With four patents to his name, his work primarily focuses on novel chemical compounds that possess cytotoxic activity, particularly in the realm of cancer treatment.
Latest Patents
Among his latest innovations are two notable patents related to 2', 5'-dideoxy-5-fluorouridine derivatives. These derivatives, characterized by a defined alkaloid fragment, showcase potential in the anticancer treatment of various types of cancer, including breast, cervical, lung, and nasopharynx cancers. His second patent pertains to 2', 3'-dideoxy-5-fluorouridine derivatives, which further extends the repertoire of compounds available for therapeutic applications.
Career Highlights
Piotr Ruszkowski is affiliated with Adam Mickiewicz University, where he conducts research and contributes to academic advancements. His tenure at the university has allowed him to immerse himself in innovative research, leading to significant breakthroughs in medicinal chemistry.
Collaborations
Collaboration is key in the academic and research landscape, and Piotr has worked alongside esteemed colleagues such as Lech Celewicz and Karol Kacprzak. Together, they have fostered a dynamic environment that promotes the sharing of ideas and accelerates the pace of scientific discovery.
Conclusion
Piotr Ruszkowski's work exemplifies the spirit of innovation within the pharmaceutical industry. His patents not only reflect his ingenuity as an inventor but also underscore the importance of collaboration in achieving significant advancements in cancer treatment. As research continues to evolve, his contributions will undoubtedly play a pivotal role in shaping the future of medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile